Yahoo · Sep 19, 2026
Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares
The insider still retains significant holdings, valued at $8.5 million, despite the sale.
HI
NYSE · HIMS
Hims & Hers Health, Inc.
Healthcare · Medical - Equipment & Services
$30.43
Up+$1.08 (+3.68%)
Updated Sep 23, 2026, 5:40 AM
SID Score
3.8/10
Composite research score
Smart Money
63/100
Neutral
- Market cap
- 8.28B
- P/E ratio
- 63.9
- Dividend yield
- 0.00%
- 52-week range
- $13.74 – $65.30
- Volume
- 16.65M
- Avg. volume
- 27.1M
Price performance
HIMS price history
1M range · 20 trading sessions · Daily adjusted prices
HIMS closed at $30.43 after 20 trading sessions, down 4.16% for the selected period.
- Last close
- $30.43
- Period change
- -4.16%
- Period low
- $27.44
- Period high
- $31.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $29.95 | $31.81 | $29.2167 | $30.43 | 16.65M |
| Sep 21, 2026 | $28.50 | $29.525 | $28.18 | $29.35 | 8.45M |
| Sep 18, 2026 | $28.86 | $29.01 | $27.703 | $27.99 | 9.4M |
| Sep 17, 2026 | $28.75 | $28.92 | $27.65 | $27.89 | 8.24M |
| Sep 16, 2026 | $27.76 | $28.55 | $27.46 | $28.00 | 7.35M |
| Sep 15, 2026 | $28.30 | $29.16 | $27.80 | $27.85 | 8.16M |
| Sep 14, 2026 | $27.38 | $29.44 | $27.14 | $28.81 | 11.98M |
| Sep 11, 2026 | $27.41 | $27.63 | $26.73 | $27.51 | 7.09M |
| Sep 10, 2026 | $27.30 | $28.00 | $27.1205 | $27.44 | 7.57M |
| Sep 9, 2026 | $28.10 | $28.28 | $27.27 | $27.90 | 8.44M |
| Sep 8, 2026 | $27.73 | $28.33 | $27.61 | $28.17 | 8.57M |
| Sep 4, 2026 | $27.73 | $27.95 | $27.38 | $27.71 | 7.18M |
| Sep 3, 2026 | $28.88 | $29.12 | $27.55 | $27.82 | 12.21M |
| Sep 2, 2026 | $28.33 | $29.375 | $28.15 | $28.68 | 7.9M |
| Sep 1, 2026 | $29.28 | $29.87 | $28.38 | $28.44 | 7.3M |
| Aug 31, 2026 | $28.67 | $29.7898 | $28.63 | $29.58 | 8.31M |
| Aug 28, 2026 | $31.36 | $31.40 | $28.52 | $28.84 | 14.73M |
| Aug 27, 2026 | $30.40 | $31.985 | $29.7244 | $31.66 | 9.62M |
| Aug 26, 2026 | $31.04 | $31.6295 | $29.62 | $29.83 | 11.58M |
| Aug 25, 2026 | $31.29 | $32.51 | $30.73 | $31.75 | 9.64M |
Latest HIMS news
The latest Smart Investors Daily articles mentioning HIMS.
Stock researchCompany · Overview
HIMS research
Overview
Company profile and research snapshot.
Company profile
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $42.83
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Truist Securities | Hold | — |
| Aug 21, 2026 | Barclays | Overweight | — |
| Aug 11, 2026 | Morgan Stanley | Equal-Weight | — |
| Aug 11, 2026 | TD Cowen | Hold | — |
| Aug 11, 2026 | B of A Securities | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 16, 2026
How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story
Hims & Hers Health has been hit with an FTC complaint and multiple securities class action lawsuits alleging improper sharing of sensitive health data and misleading billing practices, events that have already drawn regulatory scrutiny and legal pressure by mid‑2026. The allegations cut to the core of Hims & Hers’ telehealth model, putting its privacy assurances and subscription-based business practices under a spotlight that could reshape how it operates. Against this backdrop of FTC action...
Yahoo · Sep 15, 2026
Hims & Hers Health, Inc. (HIMS) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $27.93, indicating a -3.07% shift from the previous trading day.
Yahoo · Sep 14, 2026
HIMS Bulls Should Heed This Historic Chart Signal
History says you should avoid HIMS stock right now
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
